News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sesen Bio, Inc.
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
March 02, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
February 28, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma
February 21, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting
February 16, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger
February 16, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
February 15, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
February 14, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
February 02, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Receives NASDAQ Delisting Notice
January 30, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders
January 26, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics
January 19, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
January 04, 2023
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger
December 29, 2022
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
September 21, 2022
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™
December 09, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Strengthens Leadership Team as the Company Approaches the Potential Approval and Launch of Vicineum™
August 02, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Dr. Thomas Cannell, President and CEO of Sesen Bio, to Participate in Fireside Chat at the 2021 Jefferies Virtual Healthcare Conference
May 27, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Dr. Thomas Cannell, President and CEO of Sesen Bio, and Dr. Michael Jewett, FRCSC, FACS, to Participate in Canaccord Genuity “Horizons in Oncology” Virtual Conference
April 08, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Tickers
SESN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.